KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Encompass Health (EHC) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Encompass Health (EHC) over the last 17 years, with Q3 2025 value amounting to $30.8 million.

  • Encompass Health's Interest Expenses fell 1174.79% to $30.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $126.0 million, marking a year-over-year decrease of 954.77%. This contributed to the annual value of $137.4 million for FY2024, which is 425.09% down from last year.
  • As of Q3 2025, Encompass Health's Interest Expenses stood at $30.8 million, which was down 1174.79% from $30.4 million recorded in Q2 2025.
  • In the past 5 years, Encompass Health's Interest Expenses registered a high of $60.4 million during Q2 2022, and its lowest value of $30.4 million during Q2 2025.
  • In the last 5 years, Encompass Health's Interest Expenses had a median value of $36.3 million in 2023 and averaged $37.6 million.
  • As far as peak fluctuations go, Encompass Health's Interest Expenses soared by 4449.76% in 2022, and later plummeted by 3990.07% in 2023.
  • Quarter analysis of 5 years shows Encompass Health's Interest Expenses stood at $40.0 million in 2021, then dropped by 6.25% to $37.5 million in 2022, then fell by 6.93% to $34.9 million in 2023, then decreased by 5.44% to $33.0 million in 2024, then decreased by 6.67% to $30.8 million in 2025.
  • Its Interest Expenses was $30.8 million in Q3 2025, compared to $30.4 million in Q2 2025 and $31.8 million in Q1 2025.